The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2165 participants.
Also called NCT01608724
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,165 participants
- Sponsor
- Registry
-
NCT01608724
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01608724. Non-randomized; no masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2014-05 (actual). Results posted on 2016-02-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus
- Acronym
- SUNSHINE
- Condition
- Diabetes Mellitus, Non-Insulin-Dependent
- Intervention (Drug)
- Saxagliptin
- Lead sponsor
- AstraZeneca
Record details
- Record id
cardio:ct-nct01608724- Content hash
8b3f6e08032ebd5d4730ea90f43f557e049d2297f5e80562bc2cf632272800ee